Preparation and In-vitro Evaluation of Metformin Microspheres Using Non-Aqueous Solvent Evaporation Technique by Garud, N & Garud, A
de Sousa et al 
Trop J Pharm Res, August 2012;11 (4): 577 
Tropical Journal of Pharmaceutical Research August 2012; 11 (4): 577-583 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, 300001 Nigeria.  
All rights reserved. 
 






Preparation and In-vitro Evaluation of Metformin 
Microspheres Using Non-Aqueous Solvent 
Evaporation Technique 
 
Navneet Garud*and Akanksha Garud 






Purpose: To prepare and evaluate metformin microspheres for prolonged release. 
Methods: Metformin microspheres were prepared by non-aqueous solvent evaporation method using 
various polymers, including ethylcellulose (EC), hydroxypropyl methylcellulose (HPMC), carbopol 934P 
(CA) and chitosan (CH). The effect of process variables, viz, drug/polymer ratio, stirring rate and type of 
polymer on the mean particle size, drug entrapment efficiency, yield, drug content, micromeritic 
properties and drug release of the microspheres were studied.  
Results: It was observed that as the stirring speed increased from 600 to 1800 rpm, microsphere size 
decreased and hence drug release rate increased. Drug release rate at 1:2 drug: polymer for 
microspheres produced at a stirring rate of 1200 rpm was in the following order: carbopol 934P > HPMC 
> ethyl cellulose > chitosan. The formulations containing carbopol 934P (CA3) and HPMC (HPMC3) 
released drug faster than chitosan microspheres (CH3). 
Conclusion: Amongst the developed microspheres, CH3 formulation (with chitosan as the polymer) 
exhibited maximum prolonged drug release at gastrointestinal pH or at least 15 h. This oral sustained 
metformin formulation could potentially improve the bioavailability of the drug as well as patient 
compliance. 
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INTRODUCTION 
 
Microspheres have gained wide acceptance 
as a means to achieve oral and parenteral 
controlled drug delivery systems. They often 
require a polymer as carrier as well as core 
material [1]. Among the various methods 
developed for the formulation of 
microspheres, the solvent evaporation 
method has gained much attention due to its 
ease of fabrication without compromising the 
activity of the drug.  
 
Ethyl cellulose, a non-ionic, inert 
hydrophobic, non-biodegradable and 
biocompatible polymer with minimal toxicity. It 
is one of the extensively studied 
encapsulating materials for the controlled 
release of pharmaceuticals [2]. HPMC is a 
non-ionic, swellable polymer. Hydrophilic 
polymer gel matrix systems are widely used 
in controlled drug delivery to obtain a 
desirable drug release profile and cost 
effectiveness because of their flexibility. The 
hydration rate of HPMC increases with 
increase in the hydroxypropyl content. 
Carbopol is a polymer consisting of acrylic 
acid cross-linked with either polyalkenyl ether 
or divinyl glycol. It readily absorbs water, gets 
hydrated and swell. In addition to its 
hydrophilic nature, cross-linked structure and 
insolubility in water, carbopol is an anionic 
polymer, and hence a potential candidate for 
use in controlled release drug delivery [3]. 
 
The use of natural polymers is preferred due 
to their proven biocompatibility and safety. In 
this respect, chitosan, a cationic polymer, has 
attracted particular attention. It is 
biocompatible, biodegradable and  
bioadhesive at physiological pH and 
possesses OH and NH2 groups that can give 
rise to hydrogen bonding. It is a high 
molecular weight polysaccharide, comprising 
of glucosamine and N-acetyl glucosamine 
obtained by deacetylation of chitin [4]. 
Because of its low production cost, non-toxic 
nature, and FDA approval, chitosan has 
found application in multiparticulate drug 
delivery [5].   
Diabetes mellitus (DM) is the name given to a 
group of disorders characterized by chronic 
hyperglycemia, polyurea, polydipsia, poly-
phagia, emaciation and weakness due to 
disturbance in carbohydrate, fat and protein 
metabolism associated with absolute or 
relative deficiency in insulin secretion and/or 
insulin action. A drug of choice, either alone 
or in combination with other hypoglycemic 
agents, particularly in Type II diabetes, 
metformin, is an effective antidiabetic drug, 






Metformin hydrochloride was received as a 
gift from Sun Pharmaceuticals, Baroda, India. 
Acetone and liquid paraffin (Merck Ltd, 
Mumbai, India), ethylcellulose (EC, S.D. Fine 
Chemicals, Mumbai, India), hydroxypropyl 
methylcellulose (HPMC-E15) and carbopol-
934P (CA) (Central Drug House, Mumbai, 
India), chitosan (CH, medium viscosity grade, 
Central Institute of Fisheries Technology, 
Cochin, India. All other chemicals and 
deionised water used were of analytical 
grade. 
 
Preparation of microspheres 
 
The microspheres containing the anti-diabetic 
drug, metformin, as the core material were  
prepared by a non-aqueous solvent 
evaporation method [7]. Here, the drug (250 
mg) and the polymers (250, 500, or 750 mg) 
were mixed in acetone (8 ml) at various 
ratios. The slurry was introduced into 30 ml of 
liquid paraffin while stirring (600, 1200 or 
1800 rpm) with a mechanical stirrer equipped 
with a three-blade propeller at room 
temperature. The solution was stirred for 4 h 
to allow the solvent to evaporate and the 
microspheres were collected by filtration by 
Whatman filter paper no. 1. The 
microspheres were washed repeatedly with 
petroleum ether (40 - 60 °C) until free from 
oil. The microspheres were collected and 
dried for 3 h at room temperature and 
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subsequently stored in a desiccator over 
fused calcium chloride. 
 
The effect of process variables including 
drug/polymer ratio, stirring rate and polymer 
type on mean microsphere size, drug 
entrapment efficiency, yield, drug content, 
micromeritic properties and drug release was 
studied. Metformin microspheres were 
prepared in varying drug/polymer ratio (see 
Table 1) while keeping stirring speed (1200 
rpm) constant. Similarly, microspheres were 
prepared at various stirring rates (i.e., 600, 
1200 and 1800 rpm) while keeping 
drug/polymer ratio constant at 1:2.  
 
Evaluation of micromeritic properties of 
microspheres 
 
The microspheres were characterized for 
their micromeritic properties -  angle of 
repose, bulk density, tapped density, Carr’s 
index, and Hausner’s ratio [7,8]. Angle of 
repose (θ) of different formulations was 
measured according to the fixed funnel 
standing method (n = 3) and calculated using  
Eq 1. 
θ = tan-1 h/r  …………………….   (1) 
where r is the radius of the cone base, and h 
the height of the base. 
 
Bulk and tapped densities were measured 
using a 10 ml graduated cylinder. The sample 
placed in the cylinder and the volume (bulk) 
noted. The cylinder was then,tapped 100 
times and the volume (tapped) again noted. 
The bulk and tapped densities were 
calculated were calculated from the ratio of 
the weight and volume as appropriate. 
Compressibility (Carr’s) index (Ci) of 
microparticles was computed according to Eq 
2. 
Ci = (Dt – Db)/ Dt × 100 …………....  (2) 
where Dt is tapped density and Db the bulk 
density. 
 
Hausner's ratio of the microparticles was 
determined as in Eq 3. 
 
Hausner's ratio = Dt/Db …………… (3) 
 
Morphology and particle size  
 
The shape and surface characteristics of the 
microspheres were studied using scanning 
electron microscope (SEM, LEO – 430, Leo 
Electron Microscopy Ltd., Cambridge, 
England). The microparticles were coated 
uniformly with gold-palladium by using a 
sputter coater (Polaron SC-76430) after fixing 
the sample in individual stubs. The operating 
parameters were an acceleration voltage of 
20kV and chamber pressure of 0.6 mm Hg (n 
= 3). Size distribution based on mean 
diameter of the microspheres was 
determined by optical microscopy method 
[8,9]. Approximately, 100 microspheres were 
counted using a calibrated optical microscope 
(Magnus MLX-DX) and mean particle size 
was calculated. 
 
Evaluation of entrapment efficiency, drug 
loading and yield 
 
Microspheres (50 mg) were treated with 50 
ml. of phosphate buffer (pH 6.8), in 100 ml. 
amber coloured vial with stirring at 250 rpm. 
The temperature was maintained at 37 ± 0.2 
ºC. At the end of 2 h, it was filtered and the 
filtrate analyzed spectrophotometrically (n = 
3) at 232 nm (Shimadzu, Pharmspec UV-
1700 series, Japan). Drug entrapment 
efficiency, drug loading and yield were were 
calculated using Eqs 4 - 6 [10]. 
 
Drug entrapment (%) = (A/T)100 ….. (4)  
 
where A is actual drug concentration and T is 
the theoretical drug concentration.  
 
Drug loading (%) = (Wd/Wm)100 ……  (5) 
 
where Wd is the weight of drug and Wm the 
weight of the microspheres. 
 
Yield (%) = (Wm/Wdp)100 …………...  (6) 
 
where Wdp is the expected total weight of 
drug and polymer.               
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In-vitro drug release studies 
 
The in-vitro drug release profiles of the 
various microsphere formulations were 
studied in 900 ml of buffer in simulated 
gastrointestinal pH conditions, viz, simulated 
gastric fluid (0.1M HCl, pH 1.2) for the first 2 
h followed by 4 h in simulated intestinal fluid 
(phosphate buffer solution, PBS, pH 6.8) and 
finally for 9 h in simulated intestinal fluid 
(phosphate buffer solution, PBS, pH 7.4) [11]. 
Samples (5 ml) were withdrawn at various 
time intervals, and replaced with the same 
volume of test medium to maintain sink 
conditions. The withdrawn samples were 
diluted, where necessary, filtered through a 
0.45µ membrane filter and analyzed for 
metformin content at 232 nm using Shimadzu 





Experimental results (n = 3) were expressed 
as mean ± S.D. One-way ANOVA was 
performed using Sigma Stat software (SPSS 
Inc, USA) for Windows, version 2.30.  







Scanning electron microphotographs showed 
that the microspheres were spherical with a 
smooth to rough surface (Fig 1). Pores were 
observed on the microsphere surface. 
Increasing polymer concentrations (i.e., drug-
polymer ratio from 1:1 to 1:3) increased 
microsphere size from 352.1 ± 7.5 to 374.2 ± 
7.8 μm for ethylcellulose, 359.3 ± 4.1 to 388.4 
± 8.8 μm for HPMC, 424.5 ± 8.6 to 450.3 ± 
8.8 μm for carbopol 934P, and 408.6 ± 10.6 
to 426.8±8.2 μm for chitosan. However, in all 
cases, the increase was not significant (p > 
0.05). 
 
Increase in stirring rate from 600 rpm to 1800 
rpm also seemed to have decreased 
microsphere size but the decrease was not 




Fig 1: Scanning electron microphotographs 
(SEM) of metformin microspheres prepared with 
HPMC using solvent evaporation method 
 
Microsphere yield was > 56.8 % for all the 
formulations while entrapment efficiency (%) 
ranged 56.4 ± 2.4 to 85.4 ± 3.4 for EC 
microspheres, 68.1 ± 4.2 to 85.5 ± 3.9 for 
HPMC microspheres, 64.1 ±4.8 to 85.2 ± 5.3 
for CA microspheres and 61.2 ± 3.3 to 83.5 ± 
5.1 for CH microspheres (Table 1). 
 
Micromeritic properties of microspheres 
 
All the formulations showed angle of repose 
in the range of 25° to 34°. Compressibility, 
i.e., Carr’s index, was between 11.0 and 15.5 
% and Hausner’s ratio < 1.2, all the 
parameters indicating good flow property. Of 
particular note are formulations EC5 and CA5 
which showed the best flow properties (Table 
2). 
 
In-vitro drug release of microspheres 
 
Drug release (for 1:3 drug/polymer ratio) after 
15 h was in the rank order: carbopol 934P > 
HPMC > ethyl cellulose > chitosan (Fig 2), 
with the formulation prepared with carbopol 
934P releasing approximately 94.8 % of drug 
after 15 h.  
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Table 1: Characteristics of metformin microspheres prepared using solvent evaporation method (mean ± 











EC1 1:1 1200 42.1 67.85±6.1 56.8 
EC2 1:2 1200 34.6 78.68±4.3 59.8 
EC3 1:3 1200 26.5 85.42± 3.4 65.3 
EC4 1:2 600 28.2 56.36± 2.4 62.5 
EC5 1:2 1800 29.5 72.21±1.3 58.8 
HPMC1 1:1 1200 43.7 69.23± 2.8 64.9 
HPMC2 1:2 1200 45.3 73.92± 4.8 71.8 
HPMC3 1:3 1200 25.8 85.54± 3.9 78.3 
HPMC4 1:2 600 27.5 68.13± 4.2 72.8 
HPMC5 1:2 1800 28.6 71.8±2.2 66.1 
CA1 1:1 1200 44.8 70.23± 3.9 68.7 
CA2 1:2 1200 47.1 76.92± 6.0 72.2 
CA3 1:3 1200 26.2 85.22± 5.3 83.2 
CA4 1:2 600 28.4 64.12± 4.8 76.5 
CA5 1:2 1800 29.8 67.87±2.4 70.2 
CH1 1:1 1200 37.6 62.23± 3.3 59.7 
CH2 1:2 1200 40.2 78.29± 4.8 71.4 
CH3 1:3 1200 23.6 83.51± 5.1 82.3 
CH4 1:2 600 28.7 69.23± 3.3 73.8 
CH5 1:2 1800 30.6 61.23± 3.3 68.9 
 
Key: EC = ethylcellulose, HPMC = hydroxypropyl methylcellulose, CA = carbopol 934P, and CH = 
chitosan, microspheres 
 

















EC1 352.1 ± 7.5 0.720 0.625 13.19 1.15 31°12´ 
EC2 361.4 ± 6.2 0.663 0.582 12.22 1.14 29°18´ 
EC3 374.2 ± 7.8 0.659 0.568 13.81 1.16 27°34´ 
EC4 396.5 ± 7.6 0.608 0.514 15.46 1.18 25°43´ 
EC5 338.1±4.5 0.627 0.556 11.35 1.13 33°52´ 
HPMC1 359.3 ± 4.1 0.675 0.588 12.89 1.15 32°14´ 
HPMC2 375.6 ± 6.2 0.647 0.563 12.98 1.15 29°26´ 
HPMC3 388.4 ± 8.8 0.625 0.548 12.32 1.14 27°42´ 
HPMC4 410.2 ± 6.4 0.566 0.486 14.13 1.17 26°27´ 
HPMC5 352.6±5.2 0.583 0.516 11.49 1.13 33°88´ 
CA1 424.5 ± 8.6 0.617 0.535 13.29 1.15 30°20´ 
CA2 432.1 ± 9.2 0.584 0.512 12.33 1.14 29°12´ 
CA3 450.3 ± 8.8 0.556 0.489 12.05 1.14 27°24´ 
CA4 484.7 ± 4.2 0.497 0.424 14.69 1.17 26°45´ 
CA5 412.5 ±5.6 0.516 0.458 11.36 1.13 31°81´ 
CH1 408.6 ± 10.6 0.562 0.482 14.23 1.17 33°18´ 
CH2 417.2 ± 5.8 0.550 0.474 13.82 1.16 31°24´ 
CH3 426.8 ± 8.2 0.539 0.466 13.54 1.16 29°82´ 
CH4 458.1 ± 5.7 0.490 0.416 15.28 1.18 27°65´ 
CH5 385.7 ± 6.8 0.505 0.441 12.74 1.15 33°91´ 
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Fig 2: Metformin release from microspheres (1:3 
drug:polymer) ratio. Key: ■ = EC, Δ = HPMC, ♦ = 
CA, × = CH 
 
Increase in stirring speed from 600 rpm to 
1800 rpm enhanced drug release rate. At 
1800 rpm, complete drug release was 
observed except for chitosan microspheres. 
Fig 3 shows that the difference in drug 
release pattern among the various polymer 
types was not significant (p > 0.05). 
 
 
Fig 3: Metformin release from microspheres 
prepared at stirring speed of 1200 rpm by solvent 
evaporation method (Key: ♦ = EC,  = HPMC, ▲= 




Increase in polymer concentration from 1:1 to 
1:3 (drug:polymer) increased yield and 
entrapment efficiency probably because with 
increasing polymer content, more particles of 
metformin would be coated leading to higher 
encapsulation efficiency [12]. However, this 
increase was not significant. 
 
The pores on the microsphere surface of 
some formulations indicate leaching of the 
drug during dissolution prior to gelation of the 
polymeric surface. It was observed that as 
the drug-polymer concentration increased, 
the percentage entrapment efficiency 
increased whereas the percentage yield 
decreased. 
 
Increase in the particle size of the 
microspheres can be attributed to increase in 
viscosity with increasing polymer 
concentrations, which resulted in large 
emulsion droplets [13,14]. Shearing efficiency 
during stirring also diminishes at higher 
viscosities, thus resulting in the formation of 
larger droplets and hence bigger particles 
[15].   
 
As drug:polymer ratio was varied from 1:1 to 
1:3, with the consequent increase in the 
polymer content, drug release rate gradually 
decreased. The increased density of the 
polymer matrix at higher polymer 
concentrations results in increased diffusional 
pathway decreasing overall drug release from 
the polymer matrix [17]. Furthermore, smaller 
microspheres formed at lower polymer 
concentrations have a larger surface area 
exposed to the dissolution medium, thus 
leading faster drug release. The 
microspheres prepared with EC, HPMC and 
CA completely released the drug after 12 h. 
However, sustained drug release was 
observed for microspheres formulated with 
chitosan polymer extending to 15 h.  
 
The drug release was slower at acid pH than 
at alkaline pH. However, when chitosan was 
used as the polymer, more drug was 
released (34 %) at acid pH in 2 h at a stirring 
speed of 1800 rpm. This is due to the 
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CONCLUSION 
 
Varying degrees of sustained metformin 
release were obtained for microspheres 
formulated EC, HPMC, CA and CH with CH 
microspheres being the most drug sustaining 
of them all. Therefore, the developed 
formulations, prepared by non-aqueous 
solvent evaporation method, are promising 
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